2026-01-11 - Analysis Report
# ğŸ“ˆ ASML Holding NV ADR â€“ Quick Market Snapshot  

---

## 1ï¸âƒ£ Return Comparison  
- **ASML cumulative return:** **+114.50â€¯%**  
- **VOO (S&Pâ€¯500) cumulative return:** **+94.03â€¯%**  
- **Absolute divergence:** **+20.5â€¯%** (ASML outperformed VOO by 20.5â€¯%)  
- **Relative divergence:** **39.2â€¯%** â€“ ASML is in the **topâ€‘40â€¯%** of its historic fluctuation range.  

> *Interpretation:* ASML has outperformed the benchmark over the period, but its performance still lies below the upper envelope of past extremes (â‰ˆâ€¯131â€¯% max, â€‘51â€¯% min).

---

## 2ï¸âƒ£ Alpha / Beta Snapshot  
- **CAGR (2019â€‘2021)**: **+149â€¯%** â€“ the best decadeâ€‘wide period.  
- **MDD (2021â€‘2023)**: **â€‘54.1â€¯%** â€“ sharp drawdown amid market stress.  
- **Alpha (2021â€‘2023)**: **â€‘41â€¯%** â€“ underperformed its beta of 1.8.  
- **Beta**: **1.8â€“2.0** in recent periods â€“ ASML moves strongly with the market.  

> **Takeaway:** ASML delivers very high returns when the tech cycle is positive, but the volatility (high beta) and recent drawdowns mean risk is still significant.

---

## 3ï¸âƒ£ Shortâ€‘Term Price & Moving Averages  
| Metric | Value |
|--------|-------|
| Close | **$1,273.88** |
| 5â€‘day SMA | **$1,233.41** |
| 20â€‘day SMA | **$1,113.56** |
| 60â€‘day SMA | **$1,068.48** |

- **Trend:** The stock sits above all three SMAs, signaling a bullish shortâ€‘term trajectory.  
- **Momentum:** Recent daily change of **+6.66â€¯%** from the prior close indicates a sharp rebound.

---

## 4ï¸âƒ£ Technical / Risk Signals  
| Indicator | Value |
|-----------|-------|
| RSI | **83.81** â€“ overâ€‘bought territory.  
| PPO | **+1.56â€¯%** â€“ bullish but modest.  
| MRI | **0.70** â€“ *medium* investment risk.  
| Î”â€¯Relative Divergence (20â€¯days) | **+8.5â€¯%** â€“ improving.  
| 7â€‘day Rank change | **+5** â€“ climbing.  
| 7â€‘day Dynamic Expected Return | **â€‘18.3â€¯%** â€“ deteriorating.  
| Expected Return (longâ€‘term) | **39.2â€¯%** versus S&Pâ€¯500. |

**Bottom line:**  
- High RSI suggests a potential pullâ€‘back is due, but the upward momentum and favorable relative divergence give room to stay invested.  
- MRI indicates moderate risk, consistent with the high beta noted earlier.  
- The 39.2â€¯% expected excess return underscores why ASML remains a topâ€‘tier growth pick.

---

## 5ï¸âƒ£ News Highlights (Janâ€¯2026)  
- **Janâ€¯10:** *Could Investing $10,000 in ASML Make You a Millionaire?* â€“ The Motley Fool.  
- **Janâ€¯10:** *The Only Semiconductor Stock You Need for 2026* â€“ The Motley Fool.  
- **Janâ€¯8:** *Why Bernstein Sees 2026â€“27 as â€œBig Yearsâ€ for ASML* â€“ Yahoo Finance.  
- **Janâ€¯8:** *See How ASML Thrives on Rare Bullish Inflows* â€“ Yahoo Finance.  
- **Janâ€¯6:** *5 big analyst AI moves: ASML top semis pick for 2026* â€“ Investing.com.  
- **Janâ€¯9:** *Stock Movers: Glencore, ASML, Sainsburys* â€“ Bloomberg.

**Key themes:**  
- **Positive analyst sentiment** and bullish forecasts for the upcoming 2026â€‘27 cycle.  
- **Strong inflows** and **AIâ€‘driven demand** cited as catalysts.  
- **Potential valuation upside** highlighted in multiple outlets.

---

## 6ï¸âƒ£ Analyst Consensus  
| Metric | Value |
|--------|-------|
| Consensus Rating | **Buy** |
| Mean Rating (1â€‘5) | **1.53** (â‰ˆâ€¯Buy) |
| Number of Opinions | **13** |
| Target Prices | **Avgâ€¯$1,200.82** / **Highâ€¯$1,514.13** / **Lowâ€¯$842.64** |
| Recent Rating Changes | None recorded |

> *Insight:* The consensus is bullish, with targets comfortably above the current price, suggesting upside potential. No recent downgrade or upgrade actions, implying stability in expectations.

---

## 7ï¸âƒ£ Quick Summary  
- ASML **outperformed VOO** by 20.5â€¯% in cumulative return, remaining in the upperâ€‘40â€¯% of its historical range.  
- Recent alpha peaks in 2019â€‘2021, but recent betaâ€‘driven losses highlight volatility.  
- Technicals show bullish trend, yet RSI overâ€‘bought signals caution.  
- Mediumâ€‘risk MRI and a 39.2â€¯% expected excess return make it an attractive longâ€‘term play.  
- News and analyst sentiment reinforce a **buy** stance with strong upside in 2026â€‘27.  

**Recommendation:** Hold for the mediumâ€‘term; monitor RSI and drawdowns closely, but the overall outlook remains positive.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.